[Current status: hormone substitution and risk of endometrial carcinoma].
Kuhl
H
H
D016022:Case-Control Studies; D004334:Drug Administration Schedule; D004714:Endometrial Hyperplasia / Q000139:chemically induced / Q000517:prevention & control; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors
D045167:Progesterone Congeners